Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HiV1- Positive”

137 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 137 results

Post-approval studies (Phase 4)Study completedNCT01608269
What this trial is testing

Nucleoside Switch Pilot for Virologically Controlled HIV Subjects With Decreasing CD4 Cells Who Have Received TDF-based ARV Therapy

Who this might be right for
HiV1- Positive
Therapeutic Concepts 30
Not applicableStudy completedNCT00000895
What this trial is testing

Learn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With Advanced HIV Infection

Who this might be right for
Mycobacterium Avium-intracellulare InfectionHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 85
Not applicableStudy completedNCT02926456
What this trial is testing

Study in HIV1-Positive, Virosuppressed Patients Currently inTreatment With Ritonavir-Boosted Protease Inhibitors (PI/r) Starting Cobicistat-Boosted Darunavir (DRV/c - Rezolsta)

Who this might be right for
Human Immunodeficiency Virus
Janssen-Cilag S.p.A. 337
Post-approval studies (Phase 4)Ended earlyNCT01014481
What this trial is testing

Appropriate Timing of HAART in Co-infected HIV/TB Patients

Who this might be right for
HIV InfectionsTuberculosis
Bamrasnaradura Infectious Diseases Institute 156
Large-scale testing (Phase 3)Study completedNCT01968551
What this trial is testing

Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive Adults

Who this might be right for
HIV-1HIV InfectionsAcquired Immunodeficiency Syndrome
Gilead Sciences 158
Not applicableWithdrawnNCT00001080
What this trial is testing

Effect of Vaccination on Turnover of Lamivudine (3TC) Sensitive and Resistant Virus Populations in HIV-1-Infected Individuals

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Early research (Phase 1)UnknownNCT00006209
What this trial is testing

Tucaresol in HIV-Infected Patients Who Are Taking Other Anti-HIV Drugs

Who this might be right for
HIV Infections
Aaron Diamond AIDS Research Center 24
Not applicableStudy completedNCT00736502
What this trial is testing

PMS Assessing the Long-term Efficacy and Safety of Nevirapine Therapy (Combined With Other ARV Drugs) in HIV-1 Positive Patients in Daily Clinical Practice.

Who this might be right for
HIV Infections
Boehringer Ingelheim 280
Not applicableWithdrawnNCT03660722
What this trial is testing

Bone, Inflammation, Gut and Renal Biomarkers in Antiretroviral Naïve HIV-1 Positive Subjects

Who this might be right for
HIV Positive
Centre Hospitalier Universitaire de Saint Etienne
Large-scale testing (Phase 3)Study completedNCT03446573
What this trial is testing

Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)

Who this might be right for
HIV Infections
ViiV Healthcare 743
Early research (Phase 1)Study completedNCT00334659
What this trial is testing

Investigate the Cardiovascular Safety of Apricitabine in Healthy Subjects

Who this might be right for
HIV Infections
Avexa 37
Testing effectiveness (Phase 2)Study completedNCT00002235
What this trial is testing

A Study on the Safety and Effectiveness of Twice-Daily Nelfinavir Plus Twice-Daily Indinavir Plus Efavirenz in HIV-Positive Patients Who Have Never Taken Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) or Protease Inhibitors

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 6
Testing effectiveness (Phase 2)Study completedNCT02651259
What this trial is testing

Evaluating PK, Tolerability, and Safety of Rifapentine and Isoniazid in Pregnant and Postpartum Women

Who this might be right for
Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 50
Early research (Phase 1)Study completedNCT01894776
What this trial is testing

A Drug Interaction Study Investigating the Effect of Rifabutin on the Pharmacokinetics of Maraviroc

Who this might be right for
HIV InfectionHIV-1 InfectionMycobacterium Avium Complex (MAC)
Ottawa Hospital Research Institute 15
Very early researchActive Not RecruitingNCT03729778
What this trial is testing

Impact of HIV-1 and Aging on Mucosal Vaccine Responses

Who this might be right for
HIV-1-infectionHuman Immunodeficiency VirusHIV/AIDS+1 more
VA Eastern Colorado Health Care System 100
Early research (Phase 1)Study completedNCT04424264
What this trial is testing

The Effect of Rifampicin on the Pharmacokinetics of Intracellular Tenofovir-diphosphate and Tenofovir When Coadministered With Tenofovir Alafenamide Fumarate During the Maintenance Phase of Tuberculosis Treatment in TB/HIV-1 Coinfected Participants

Who this might be right for
HIV-1-infectionTuberculosis
Professor Francois Venter 18
Not applicableStudy completedNCT00001119
What this trial is testing

Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 288
Early research (Phase 1)Study completedNCT00000952
What this trial is testing

Ritonavir (an Anti-HIV Drug) in HIV-Positive Infants and Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 60
Not applicableStudy completedNCT00002354
What this trial is testing

Indinavir Sulfate Given Together With Stavudine to HIV-Positive Patients

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 540
Early research (Phase 1)Study completedNCT00000944
What this trial is testing

Evaluate the Safety and Tolerance of Combination Anti-HIV Drug Therapy (Indinavir, Lamivudine, and Zidovudine) in HIV-Positive Pregnant Women and Their Infants

Who this might be right for
HIV InfectionsPregnancy
National Institute of Allergy and Infectious Diseases (NIAID) 24
Next Page